Skip to content

Arvinas ARVN Net Income

Net Income at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$87.17M-54.7%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-$69.23M-5.6%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
-$44.5M-195%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-$19.05M-8.5%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
-$6.05M-13.5%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-$43.32M+32.7%

Segments

By segment

See full
Reportable Segment-$57.6M-169%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's net income?
Arvinas (ARVN) reported net income of -$57.6M in Q1 2026.
How has Arvinas's net income changed year-over-year?
Arvinas's net income decreased by 169.5% year-over-year, from $82.9M to -$57.6M.
What is the long-term trend for Arvinas's net income?
Over 4 years (2021 to 2025), Arvinas's net income has grown at a -19.4% compound annual growth rate (CAGR), from -$191.1M to -$80.8M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.